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Chemical biology is an interdisciplinary field of study that is often defined as “chemistry-initiated biology.” As biolog-
ical processes all stem from chemical events, it should be possible to understand or manipulate biological events using 
chemistry. Our laboratory has been discovering or designing unique organic molecules that modulate fundamental pro-
cesses in human cells. Such synthetic organic molecules often serve as tools for basic cell biology. Discovery or design of 
small molecules with unique biological activities permits small-molecule-initiated exploration of complex cellular events. 
Our mission is to create a new world of bioactive synthetic 
molecules: new modes of activity, new shapes, and new 
 sizes. We hope to open new avenues for small-molecule 
 applications in a range of fields, including future concepts in 
drug discovery and use of small molecules for cell therapy.
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Small-molecule Screening Yields a Compound 
That Inhibits the Cancer-associated Transcrip-
tion Factor Hes1 via the PHB2 Chaperone
The transcription factor Hes family basic helix-loop- 
helix transcription factor 1 (Hes1) is a downstream effector 
of Notch signaling and plays a crucial role in orchestrating 
developmental processes during the embryonic stage. 
However, its aberrant signaling in adulthood is linked to 
the pathogenesis of cancer. In the present study, we report 
the discovery of small organic molecules (JI051 and JI130) 
that impair the ability of Hes1 to repress transcrip-
tion. Hes1 interacts with the transcriptional corepressor 
transducing-like enhancer of split 1 (TLE1) via an inter-
action domain comprising two tryptophan residues, prompt-
ing us to search a chemical library of 1,800 small molecules 
enriched for indole-like π-electron–rich pharmacophores 
for a compound that blocks Hes1-mediated transcriptional 
repression. This screening identified a lead compound 
whose extensive chemical modification to improve po-
tency yielded JI051, which inhibited HEK293 cell pro-
liferation with an EC50 of 0.3 μM. Unexpectedly, using 
immunomagnetic isolation and nanoscale LC-MS/MS, we 
found that JI051 does not bind TLE1 but instead interacts 
with prohibitin2 (PHB2), a cancer-associated protein chap-
erone. We also found that JI051 stabilizes PHB2’s interac-
tion with Hes1 outside the nucleus, inducing G2/Mcell- 
cyclearrest. Of note, JI051 dose-dependently reduced cell 
growth of the human pancreatic cancer cell line MIA 
PaCa-2, and JI130 treatment significantly reduced tumor 
volume in a murine pancreatic tumor xenograft model. 
These results suggest a previously unrecognized role for 
PHB2 in the regulation of Hes1 and may inform potential 
strategies for managing pancreatic cancer.
Chemical Decontamination of iPS Cell-derived 
Neural Cell Mixtures
This report describes the design and evaluation of phos-
phorylated 7-ethyl-10-hydroxycamptothecin (SN38-P), 
which selectively eliminates tumor-forming proliferative 
stem cells, including human induced pluripotent stem cells 
(hiPSCs) and neural stem cells, from iPSC-derived neural 
cell mixtures. Results of the present study demonstrate that 
simple phosphorylation of an anticancer drug can provide 
a safe, cost-effective, and chemically-defined tool for de-
contaminating hiPSC-derived neuron.
